| 14.01 Delayed Data As of Oct 11 |  -0.08 / -0.57%Today’s Change | 10.22 Today|||52-Week Range 30.25 | +17.73% Year-to-Date |
| Previous close | 14.09 |
| Today’s open | 14.20 |
| Day’s range | 13.95 - 14.55 |
| Volume | 179,207 |
| Average volume (3 months) | 517,643 |
| Market cap | $387.8M |
| Earnings growth (last year) | -611.33% |
| Earnings growth (this year) | -85.81% |
| Earnings growth (next 5 years) | +47.05% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.57 |
| Today’s change | Today’s % change | |
|---|---|---|
| VRCAVerrica Pharmaceutic... | +0.18 | +1.19% |
| AMAGAMAG Pharmaceuticals... | -0.37 | -3.20% |
| TCRRTCR2 Therapeutics In... | +0.80 | +5.40% |
| COLLCollegium Pharmaceut... | -0.11 | -0.92% |
| Next reporting date | November 7, 2019 |
| EPS forecast (this quarter) | -$1.16 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$46.9M |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Major |
President, Chief Executive Officer & Director David Moatazedi |
Vice President- Operations Alejandro Sabad |
Corporate headquarters Newport Beach, California |
